References
- Hoyt WF, Meshel LG, Lessell S, Schatz NJ, Suckling RD. Malignant optic glioma of adulthood. Brain. 1973;96(1):121–132. doi:10.1093/brain/96.1.121.
- Traber GL, Pangalu A, Neumann M, et al. Malignant optic glioma – the spectrum of disease in a case series. Graefe’s Arch Clin Exp Ophthalmol. 2015;253(7):1187–1194. doi:10.1007/s00417-015-3045-8.
- Wen PY, Weller M, Lee EQ, et al. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020;22(8):1073–1113. doi:10.1093/neuonc/noaa106.
- Ramakrishnan MS, Vora RA, Gilbert AL. Glioblastoma multiforme mimicking optic neuritis. Am J Ophthalmol Case Rep. 2020;17:100594. doi:10.1016/j.ajoc.2020.100594.
- Deng S, Li Y, Guan Y, Xu S, Chen J, Zhao G. Gliomas in the sella turcica region: a retrospective study including adult cases and comparison with craniopharyngioma. Eur Neurol. 2015;73(3–4):135–143. doi:10.1159/000369794.
- Wang J, Liu Z, Du J, et al. The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma: the clinicopathology of pituicytoma. Neuropathology. 2016;36(5):432–440. doi:10.1111/neup.12291.
- Behnan J, Finocchiaro G, Hanna G. The landscape of the mesenchymal signature in brain 170 tumours. Brain. 2019;142(4):847–866. doi:10.1093/brain/awz044.
- Campbell A, Gartrell-Corrado R, Mansukhani M et al. SETD2 mutation in an 172 aggressive optic nerve glioma. JAMA Ophthalmol. 2020;138(1):102–104. doi:10.1001/jamaophthalmol.2019.4511.